Study Title
Prospective non-randomized, multi-center, diagnostic performance study of 18FDG PET for identification of early tumor escape to immunotherapy in patients with unresectable melanoma or Broncho-Pulmonary Carcinoma No to Advanced or Metastatic Small Cells
Study Details
Description:
The hypothesis of this diagnostic performance study is that, for patients treated for immunotherapy-treated melanoma or NSCLC, some metabolic parameters of the 18FDG dual-point PET scan distinguish inflammatory pseudo-progression from tumor progression true and thus improve the evaluation of tumor response to immunotherapy
Sponsor:
Centre Antoine Lacassagne
Contacts:
OLIVIER HUMBERT, PHDolivier.humbert@nice.unicancer.fr
+33492031310
Jacques DARCOURT, PHDjacques.darcourt@nice.unicancer.fr
+33492031098
Government Study Link:
NCT03584334 - Click here to see study onClinicalTrials.gov